Incorrect. Fluff news would be to say there is a study being conducted and we anticipate that the results will be better than expected. "RCHA reports, "In one of the studies with 52 patients, all but one of the patients treated with an infusion of our drug TPA increased the number of WBCs, some significantly. We know that WBCs are key to fighting disease and are vital to many patients' treatment and recovery," said Rich Pharmaceuticals CEO Ben Chang." That is honest, solid information provided to shareholders who have an interest in knowing how these studies etc are coming along. $RCHA PEPSI